Though people have shared personal stories of the medications sometimes surprising side effects, such as pregnancy, and individual studies have hinted at new benefits and risks, there have been few studies that have been able to take a comprehensive look at how these medications, which include Ozempic, Wegovy, Mounjaro and Zepbound, may change a persons overall health
In a recently completed phase 2 trial (abstract data), 46 weeks of survodutide once weekly (0.6 to 4.8 mg) resulted in a dose-dependent mean WL up to 18.7% vs
How do they work in the brain
Studies in knock-out mice confirmed the biological action of [dA(2)]GLP-1/GcG which is related to its ability to target GIP, GLP-1, and glucagon receptors
But the gap between what patients fear and what the trial data shows is substantial
Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, et al